Published in Semin Thorac Cardiovasc Surg on January 01, 2002
Diastolic dysfunction: can it be diagnosed by Doppler echocardiography? J Am Coll Cardiol (2004) 3.89
Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation (2003) 2.57
Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation (2003) 2.46
Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J Am Coll Cardiol (2007) 2.30
Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration. Heart Rhythm (2006) 2.13
Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J Card Fail (2005) 2.11
Baseline left ventricular volume and shape as determinants of reverse remodeling induced by surgical ventricular reconstruction. Ann Thorac Surg (2011) 2.07
Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction. Hypertension (2006) 1.87
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J (2008) 1.83
Impact of surgical ventricular reconstruction on stroke volume in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg (2010) 1.79
PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure. J Cell Biol (2003) 1.78
Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. J Biol Chem (2002) 1.73
Multicenter evaluation of noninvasive cardiac output measurement by bioreactance technique. J Clin Monit Comput (2008) 1.68
Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol (2002) 1.64
The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. J Am Coll Cardiol (2007) 1.63
Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance. Am J Physiol Heart Circ Physiol (2007) 1.61
Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump. J Am Coll Cardiol (2009) 1.57
Mechanisms of heart failure with well preserved ejection fraction in dogs following limited coronary microembolization. Cardiovasc Res (2004) 1.53
Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J (2004) 1.52
The ventilatory anaerobic threshold in heart failure: a multicenter evaluation of reliability. J Card Fail (2009) 1.50
Single-beat estimation of end-diastolic pressure-volume relationship: a novel method with potential for noninvasive application. Am J Physiol Heart Circ Physiol (2006) 1.50
Outcomes following percutaneous coronary intervention in patients previously considered "without option": a subgroup analysis of the PACIFIC Trial. J Interv Cardiol (2004) 1.41
Temporary assist device for postcardiotomy cardiac failure. Ann Thorac Surg (2004) 1.40
Safety and feasibility of percutaneous delivery of a novel circulatory assist device (CircuLite® SYNERGY®) in the swine model. EuroIntervention (2013) 1.39
Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation (2003) 1.32
Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process. Prog Biophys Mol Biol (2008) 1.30
Myocardial recovery and the failing heart: myth, magic, or molecular target? J Am Coll Cardiol (2012) 1.17
Left ventricular form and function: scientific priorities and strategic planning for development of new views of disease. Circulation (2004) 1.16
Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol (2003) 1.15
Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation (2005) 1.14
Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J Am Coll Cardiol (2005) 1.13
Clinical benefits of partial circulatory support in New York Heart Association Class IIIB and Early Class IV patients. Eur J Cardiothorac Surg (2010) 1.12
Percutaneous mitral valve repair: a feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv (2003) 1.10
Development and validation of a patient questionnaire to determine New York Heart Association classification. J Card Fail (2004) 1.10
Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure. Am J Physiol Heart Circ Physiol (2004) 1.09
The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents. Catheter Cardiovasc Interv (2003) 1.07
Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. J Am Coll Cardiol (2007) 1.05
Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol (2008) 1.03
Heart failure with normal ejection fraction: consideration of mechanisms other than diastolic dysfunction. Curr Heart Fail Rep (2009) 1.03
End-tidal CO2 pressure and cardiac performance during exercise in heart failure. Med Sci Sports Exerc (2009) 1.01
A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J (2011) 1.01
The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences? Eur Heart J (2009) 1.00
Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support. J Heart Lung Transplant (2005) 0.98
Cardiac contractility modulation by non-excitatory currents: studies in isolated cardiac muscle. Eur J Heart Fail (2005) 0.98
Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%. Am J Cardiol (2009) 0.97
Cardiac output and cardiopulmonary responses to exercise in heart failure: application of a new bio-reactance device. J Card Fail (2007) 0.97
A computational method of prediction of the end-diastolic pressure-volume relationship by single beat. Nat Protoc (2007) 0.96
Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. Ann Thorac Surg (2002) 0.96
Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng (2003) 0.96
A multicenter study of noninvasive cardiac output by bioreactance during symptom-limited exercise. J Card Fail (2009) 0.94
First human use of partial left ventricular heart support with the Circulite synergy micro-pump as a bridge to cardiac transplantation. Eur Heart J (2008) 0.94
Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs. J Heart Lung Transplant (2005) 0.94
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev (2011) 0.94
Mechanisms underlying improvements in ejection fraction with carvedilol in heart failure. Circ Heart Fail (2009) 0.94
Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. J Card Fail (2011) 0.93
Mortality in heart failure with preserved ejection fraction: an unacceptably high rate. Eur Heart J (2011) 0.93
Electric currents applied during refractory period enhance contractility and systolic calcium in the ferret heart. Am J Physiol Heart Circ Physiol (2002) 0.93
Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling. JACC Cardiovasc Imaging (2009) 0.93
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. Am Heart J (2008) 0.92
Mechanical device-based methods of managing and treating heart failure. Circulation (2005) 0.91
Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data. J Thorac Cardiovasc Surg (2007) 0.90
Cardiac contractility modulation by electric currents applied during the refractory period. Am J Physiol Heart Circ Physiol (2002) 0.90
Surgical ventricular remodeling: a balancing act on systolic and diastolic properties. J Thorac Cardiovasc Surg (2006) 0.89
Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failure. Am J Physiol Heart Circ Physiol (2005) 0.88
Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration. J Am Coll Cardiol (2005) 0.88
Load dependence of ventricular performance explained by model of calcium-myofilament interactions. Am J Physiol Heart Circ Physiol (2002) 0.87
Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (2002) 0.87
Biventricular assist device-induced right ventricular reverse structural and functional remodeling. J Heart Lung Transplant (2005) 0.86
Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure. Congest Heart Fail (2010) 0.86
Partial left ventricular support implanted through minimal access surgery as a bridge to cardiac transplant. J Thorac Cardiovasc Surg (2008) 0.85
Bradycardic therapy improves left ventricular function and remodeling in dogs with coronary embolization-induced chronic heart failure. J Pharmacol Exp Ther (2007) 0.85
Continuous-flow left ventricular assist devices induce left ventricular reverse remodeling. J Heart Lung Transplant (2013) 0.85
Single-beat estimation of the left ventricular end-diastolic pressure-volume relationship in patients with heart failure. Heart (2009) 0.85
A polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia. Am J Physiol Heart Circ Physiol (2006) 0.84
Toward a new blood vessel. Vasc Med (2002) 0.83
The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction. J Card Fail (2011) 0.83
Myoblast transfer in ischemic heart failure: effects on rhythm stability. Cell Transplant (2009) 0.83
Elective bridging to recovery after repair: the surgical approach to ventricular reverse remodeling. Artif Organs (2008) 0.82
Hemodynamic changes as a diagnostic tool in acute heart failure--a pilot study. Am J Emerg Med (2010) 0.82
Myocardial expression levels of micro-ribonucleic acids in patients with left ventricular assist devices signature of myocardial recovery, signature of reverse remodeling, or signature with no name? J Am Coll Cardiol (2011) 0.82
Noninvasive measurement of cardiac performance in recovery from exercise in heart failure patients. Clinics (Sao Paulo) (2011) 0.81
Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure. Eur J Heart Fail (2012) 0.81
Ventricular pump function in heart failure with normal ejection fraction: insights from pressure-volume measurements. Prog Cardiovasc Dis (2006) 0.81
In vitro ablation of cardiac valves using high-intensity focused ultrasound. Ultrasound Med Biol (2005) 0.80
The conundrum of functional mitral regurgitation in chronic heart failure. J Am Coll Cardiol (2008) 0.80
Two axial-flow Synergy Micro-Pumps as a biventricular assist device in an ovine animal model. J Heart Lung Transplant (2012) 0.79
Right ventricular assist device in end-stage pulmonary arterial hypertension: insights from a computational model of the cardiovascular system. Prog Cardiovasc Dis (2012) 0.79
Chasing the elusive pressure-volume relationships. JACC Cardiovasc Imaging (2009) 0.79
Feasibility study of a temporary percutaneous left ventricular assist device in cardiac surgery. Ann Thorac Surg (2007) 0.78
Cardiomyopathic etiology and SERCA2a reverse remodeling during mechanical support of the failing human heart. Anesth Analg (2006) 0.78
A novel pulsatile, laminar flow bioreactor for the development of tissue-engineered vascular structures. Tissue Eng (2002) 0.78
Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing. Am Heart J (2002) 0.77
Is myocardial recovery possible and how do you measure it? Curr Cardiol Rep (2012) 0.76
Macrophage inhibitor, semapimod, reduces tumor necrosis factor-alpha in myocardium in a rat model of ischemic heart failure. J Cardiovasc Pharmacol (2004) 0.76
Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering. Vasc Med (2002) 0.76
Diastolic heart failure. N Engl J Med (2004) 0.76
Systolic heart failure and cardiac resynchronization therapy: a focus on diastole. Int J Cardiovasc Imaging (2014) 0.76
Evolution of renal function after partial and full mechanical support for chronic heart failure. Int J Artif Organs (2014) 0.76